Search earnings tickers

REGN

2026Q2BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-07-30 · Fiscal end 2026-06-30 · Features as of 2026-07-29

← Earnings history

Street

Consensus EPS8.00

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.2%

IV front—

P/C full—

P/C front—

Features as of2026-07-29

Run-up

Close—

Ret 5d+6.8%

Ret 10d+4.7%

Ret 20d+11.5%

Ret 30d+13.1%

Print

Actual EPS

12.53Beat

Estimated EPS8.00

Actual revenue

4.3B

Surprise %+56.6%

Beat / missBeat

Beat streak 44

Beat streak 85

Reaction

1-day stock reaction+5.2%

Implied vs actual

Implied 2.2%Actual 0.9%

Gap reaction+0.9%

Day result+6.2%

Next-day upYes

Realized / IV0.42×

Post tape

Post 5d+4.6%

Post 10d+9.2%

Post volume1.5M

Vol ×10d1.87×

Vol ×20d1.91×

Post range6.4%